AU4061599A - Aqueous preparations containing hardly soluble drug - Google Patents

Aqueous preparations containing hardly soluble drug

Info

Publication number
AU4061599A
AU4061599A AU40615/99A AU4061599A AU4061599A AU 4061599 A AU4061599 A AU 4061599A AU 40615/99 A AU40615/99 A AU 40615/99A AU 4061599 A AU4061599 A AU 4061599A AU 4061599 A AU4061599 A AU 4061599A
Authority
AU
Australia
Prior art keywords
preparations containing
hardly soluble
soluble drug
aqueous preparations
containing hardly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40615/99A
Inventor
Hiroyuki Ogawa
Hidekazu Suzuki
Masanobu Takeuchi
Koji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Publication of AU4061599A publication Critical patent/AU4061599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
AU40615/99A 1998-06-10 1999-06-10 Aqueous preparations containing hardly soluble drug Abandoned AU4061599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17654498 1998-06-10
JP10/176544 1998-06-10
PCT/JP1999/003107 WO1999063968A1 (en) 1998-06-10 1999-06-10 Aqueous preparations containing hardly soluble drug

Publications (1)

Publication Number Publication Date
AU4061599A true AU4061599A (en) 1999-12-30

Family

ID=16015451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40615/99A Abandoned AU4061599A (en) 1998-06-10 1999-06-10 Aqueous preparations containing hardly soluble drug

Country Status (2)

Country Link
AU (1) AU4061599A (en)
WO (1) WO1999063968A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4848575B2 (en) * 2000-03-30 2011-12-28 ゼリア新薬工業株式会社 A stable solution containing allantoin
JP3450805B2 (en) * 2000-08-08 2003-09-29 わかもと製薬株式会社 Aqueous pharmaceutical composition
JP4512700B2 (en) * 2003-06-02 2010-07-28 トーアエイヨー株式会社 Acyclovir-containing aqueous preparation
WO2005082335A1 (en) * 2004-02-26 2005-09-09 Kowa Company., Ltd. Ophthalmic preparation
JP2007099647A (en) * 2005-09-30 2007-04-19 Kobayashi Pharmaceut Co Ltd Composition applicable to mucosa
JP2012527491A (en) 2009-05-27 2012-11-08 サムヤン バイオファーマシューティカルズ コーポレイション Slightly soluble drug-containing microspheres with improved bioavailability and method for producing the same
JP2012017308A (en) * 2010-07-09 2012-01-26 Nipro Corp Gemcitabine aqueous solution formulation
JP5916560B2 (en) * 2012-08-08 2016-05-11 小林製薬株式会社 Mucosal composition
US20160228559A1 (en) * 2013-09-25 2016-08-11 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
EP3096740B1 (en) * 2014-01-24 2020-09-30 Sentiss Pharma Private Limited Pharmaceutical composition comprising brinzolamide
CN107397745A (en) * 2016-08-24 2017-11-28 上海毕傲图生物科技有限公司 Azole compounds eye-drops preparations
CN109260152A (en) * 2018-11-13 2019-01-25 禹州市中医院 A kind of lomefloxacin hydrochloride auristilla
WO2021001805A1 (en) * 2019-07-04 2021-01-07 Ocular Discovery Ltd. Stable dipyridamole formulations and their methods of preparation
WO2021001806A1 (en) * 2019-07-04 2021-01-07 Ocular Discovery Ltd. Stable dipyridamole formulations with reduced impurities

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2787364B2 (en) * 1990-03-29 1998-08-13 大塚製薬株式会社 Fat-soluble vitamin injection
US5516770A (en) * 1993-09-30 1996-05-14 American Home Products Corporation Rapamycin formulation for IV injection

Also Published As

Publication number Publication date
WO1999063968A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2001278779A1 (en) Aqueous suspension preparations
AU4397700A (en) Combined preparations comprising anthracycline derivatives
AU5983900A (en) Combined preparations comprising antitumor agents
ZA200104280B (en) Pharmaceutical combination preparations.
AU1548001A (en) Ophthalmic aqueous preparation
AU4328800A (en) Pharmaceutical formulation
AU4061599A (en) Aqueous preparations containing hardly soluble drug
AU5033399A (en) Aqueous polymer preparations containing pigments
AU1409100A (en) Drugs
AU3089199A (en) Preparations containing licariin
AU3929799A (en) Effervescent preparations
AU1800100A (en) Medicinal preparations
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
AU3839900A (en) Pharmaceutical formulation
AU2001282521A1 (en) OCT preparations
AU4504201A (en) Drug preparations
AU1172101A (en) Phytoestrogenic pharmaceutical preparations
AU6473699A (en) Aqueous drug formulation for oral application
AU5182099A (en) Pharmaceutical formulation
AU1388501A (en) Pharmaceutical formulation
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
AU2279800A (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase